Qureight
Qureight is a Core Imaging Laboratory that accelerates drug development through AI-powered data curation, focusing on lung and heart diseases. Their AI-powered technology stack enables collaborative analysis of imaging, clinical data, and biomarkers. The platform utilizes ML-based image algorithms for CT scans, AI-assisted workflows, and central image reads with cloud-based technology. Qureight partners with biopharma, contract research organizations, and hospitals to improve drug approval times. They also offer zero-footprint medical imaging viewing with annotation and ML model run capabilities, fast AI-guided central read image workflows, and the ability to generate synthetic study arms. The company is ISO13485 certified and compliant with GDPR, HIPAA, and 21 CFR Part 11.
Qureight
Qureight is a Core Imaging Laboratory that accelerates drug development through AI-powered data curation, focusing on lung and heart diseases. Their AI-powered technology stack enables collaborative analysis of imaging, clinical data, and biomarkers. The platform utilizes ML-based image algorithms for CT scans, AI-assisted workflows, and central image reads with cloud-based technology. Qureight partners with biopharma, contract research organizations, and hospitals to improve drug approval times. They also offer zero-footprint medical imaging viewing with annotation and ML model run capabilities, fast AI-guided central read image workflows, and the ability to generate synthetic study arms. The company is ISO13485 certified and compliant with GDPR, HIPAA, and 21 CFR Part 11.
TL;DR
What they do: AI-powered core imaging laboratory for clinical trials in lung and heart disease
Founded: 2018
Headquarters: Cambridge, United Kingdom
Certifications / compliance: ISO13485, ISO27001; GDPR, HIPAA, 21 CFR Part 11
Recent funding: Series A announced Apr 16, 2024 (led by Hargreave Hale AIM VCT)
Company Overview
Problem Domain
Imaging data curation and analysis for clinical trials in pulmonary and cardiovascular disease.
Founded
2018
Industry
Biotechnology
Tech Stack
Funding Track Record
Participating investors reported to include XTX Ventures, Playfair Capital, Nexenai Capital, Meltwind Advisory, Guinness Ventures, Cambridge Angels group, Ascension Life Fund
Investor Signal
“Company completed a Series A round led by an institutional investor with participation from venture and angel investors”